本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

Allogene Therapeutics Inc.

1.16
-0.0200-1.69%
盤後1.190.0300+2.59%19:37 EDT
成交量:379.24萬
成交額:450.52萬
市值:2.52億
市盈率:-0.88
高:1.28
開:1.19
低:1.15
收:1.18
資料載入中...
2025/04/21

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/03/14

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/03/14

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/03/14

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2025/03/14

年度報告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2025/03/13

重要事件披露

Form 8-K - Current report
2025/02/25

重要事件披露

Form 8-K - Current report
2025/02/19

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/02/03

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/02/03

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/02/03

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/02/03

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/02/03

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/01/29

重要事件披露

Form 8-K - Current report
2025/01/21

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/12/09

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/12/02

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/11/14

重要事件披露

Form 8-K - Current report
2024/11/08

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/11/07

重要事件披露

Form 8-K - Current report